Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2010

Inhalt (33 Artikel)

Review

Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer

Anne M. Friel, Claire Corcoran, John Crown, Lorraine O’Driscoll

Preclinical study

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

Ilenia Migliaccio, Meng-Fen Wu, Carolina Gutierrez, Luca Malorni, Syed K. Mohsin, D. Craig Allred, Susan G. Hilsenbeck, C. Kent Osborne, Heidi Weiss, Adrian V. Lee

Preclinical study

Subtypes of familial breast tumours revealed by expression and copy number profiling

Nic Waddell, Jeremy Arnold, Sibylle Cocciardi, Leonard da Silva, Anna Marsh, Joan Riley, Cameron N. Johnstone, Mohammed Orloff, Guillaume Assie, Charis Eng, Lynne Reid, Patricia Keith, Max Yan, Stephen Fox, Peter Devilee, Andrew K. Godwin, Frans B.L. Hogervorst, Fergus Couch, Sean Grimmond, James M. Flanagan, Kumkum Khanna, Peter T. Simpson, Sunil R. Lakhani, Georgia Chenevix-Trench

Preclinical study

Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells

Yuhua Zhang, Huaiping Wang, Lijing Wei, Guang Li, Jin Yu, Yan Gao, Peng Gao, Xiaofang Zhang, Fulan Wei, Deling Yin, Gengyin Zhou

Preclinical study

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy

Yiing Lin, Shin Lin, Mark Watson, Kathryn M. Trinkaus, Sacha Kuo, Michael J. Naughton, Katherine Weilbaecher, Timothy P. Fleming, Rebecca L. Aft

Preclinical study

Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases

Ashley Cimino, Marc Halushka, Peter Illei, Xinyan Wu, Saraswati Sukumar, Pedram Argani

Preclinical study

Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?

Rocío Soldati, Victoria Wargon, Juan Pablo Cerliani, Sebastián Giulianelli, Silvia Inés Vanzulli, María Alicia Gorostiaga, Julieta Bolado, Pablo do Campo, Alfredo Molinolo, Günter Vollmer, Claudia Lanari

Preclinical study

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Balazs Györffy, Andras Lanczky, Aron C. Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi

Preclinical study

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis

Takayuki Kobayashi, Hitoshi Tsuda, Tomoyuki Moriya, Tamio Yamasaki, Ryoko Kikuchi, Shigeto Ueda, Jiro Omata, Junji Yamamoto, Osamu Matsubara

Preclinical study

Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate

Christine Y. Shiang, Yuan Qi, Bailiang Wang, Vladimir Lazar, Jing Wang, W. Fraser Symmans, Gabriel N. Hortobagyi, Fabrice Andre, Lajos Pusztai

Preclinical study

Gene amplification in ductal carcinoma in situ of the breast

L. Burkhardt, T. J. Grob, I. Hermann, E. Burandt, M. Choschzick, F. Jänicke, V. Müller, C. Bokemeyer, R. Simon, G. Sauter, W. Wilczak, A. Lebeau

Clinical trial

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer

Janet E. Brown, Richard J. Cook, Allan Lipton, Luis Costa, Robert E. Coleman

Clinical trial

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)

Helene Svensson, Zakaria Einbeigi, Hemming Johansson, Thomas Hatschek, Yvonne Brandberg

Clinical trial

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients

Teresa Mele, Daniele Generali, Stephen Fox, Maria Pia Brizzi, Alessandra Bersiga, Manuela Milani, Giovanni Allevi, Simone Bonardi, Sergio Aguggini, Marco Volante, Luigi Dogliotti, Alberto Bottini, Adrian Harris, Alfredo Berruti

Clinical trial

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

Brenna C. McDonald, Susan K. Conroy, Tim A. Ahles, John D. West, Andrew J. Saykin

Clinical trial

Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer

Lesley-Ann Martin, Giles L. S. Davies, Marion T. Weigel, Nadine Betambeau, Margaret J. Hills, Janine Salter, Geraldine Walsh, Roger A’Hern, Mitch Dowsett

Clinical trial

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

Phuong K. Morrow, Stephen Divers, Louise Provencher, Shiuh-Wen Luoh, Teresa M. Petrella, Marius Giurescu, Thomas Schmelter, Yao Wang, Gabriel N. Hortobagyi, Linda T. Vahdat

Epidemiology

Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density

Cornelia W. Taverne, Martijn Verheus, James D. McKay, Rudolf Kaaks, Federico Canzian, Diederick E. Grobbee, Petra H. M. Peeters, Carla H. van Gils

Epidemiology

TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls

Dongying Gu, Luhong Zhuang, Huaying Huang, Ping Cao, Danling Wang, Jinhai Tang, Jinfei Chen

Epidemiology

TGF-β1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects

Yongsheng Huang, Binghui Li, Ji Qian, Jingtian Xie, Long Yu

Epidemiology

Adipocytokine resistin and breast cancer risk

Chien-An Sun, Mei-Hsuan Wu, Chi-Hong Chu, Yu-Ching Chou, Giu-Cheng Hsu, Tsan Yang, Wan-Yun Chou, Cheng-Ping Yu, Jyh-Cherng Yu

Epidemiology

NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis

Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Jia-Lei Wang, Shuang-Shuang He, Xi-Chun Hu

Epidemiology

Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women

Suleeporn Sangrajrang, Yasunori Sato, Hiromi Sakamoto, Sumiko Ohnami, Thiravud Khuhaprema, Teruhiko Yoshida

Brief Report

Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision

Isacco Montroni, Donatella Santini, Giorgia Zucchini, Monica Fiacchi, Simone Zanotti, Giampaolo Ugolini, Alessio Manaresi, Mario Taffurelli

Brief Report

Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation

A. Lasa, T. Ramón y Cajal, G. Llort, J. Suela, J. C. Cigudosa, M. Cornet, C. Alonso, A. Barnadas, M. Baiget

Letter to the Editor

Mouse mammary tumor-like virus and human breast cancer

Wendy K. Glenn, Brian Salmons, James S. Lawson, Noel J. Whitaker

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.